Sep 25 |
Terns Pharmaceuticals: Obesity Advancement Continues With Other Q1 2025 Program Catalyst
|
Sep 24 |
Insiders Snap Up These 2 ‘Strong Buy’ Stocks
|
Sep 20 |
Viking, Structure, Terns benefiting from disappointing Novo Nordisk weight loss data
|
Sep 18 |
This Small-Cap Stock Has a Promising GLP-1 Drug That Could Rival Novo Nordisk's and Eli Lilly's Weight Loss Treatments
|
Sep 17 |
OrbiMed Advisors LLC Increases Stake in Terns Pharmaceuticals Inc
|
Sep 16 |
With 55% ownership, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) boasts of strong institutional backing
|
Sep 15 |
Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.
|
Sep 15 |
Should You Invest in This Under-the-Radar Weight Loss Stock?
|
Sep 14 |
1 New Weight Loss Drug Stock to Buy Now With $1,000 and Hold for 5 Years or More
|
Sep 12 |
Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
|